Share Prices & Company Research

Market News

10 Feb 2021 | 15:30

BioNTech starts Covid-19 vaccine production at new Marburg plant

(Sharecast News) - BioNTech has started production of its Covid-19 vaccine from a new manufacturing site in Marburg, Germany.

At full capacity, the new installation will be able to make 750m doses of the vaccine annually, with the first distribution of vaccines from Marburg currently penciled-in for April.

Together with Pfizer, its partner in developing the vaccine, BioNTech is targeting full-year vaccine production of 2bn doses.

BioNTech's expected vaccine output in the first half of 2021 is expected to reach 250m doses.

Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.